Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Ophthalmic preparation
Patent
1993-08-10
1994-06-14
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Topical body preparation containing solid synthetic organic...
Ophthalmic preparation
424 781, 424 7837, 424427, 424428, 514362, 5147726, 514777, 514912, 514913, 544134, A01N 4382, A61K 3141, C07D41708, C07D41712
Patent
active
053208390
ABSTRACT:
Topical ophthalmic compositions comprising certain thiadiazoles are useful in the treatment of glaucoma and ocular hypertension. The thiadiazoles are slightly less potent than timolol; however, they have greatly reduced systemic side effects as compared to timolol.
REFERENCES:
patent: 3655663 (1972-04-01), Wasson
patent: 3657237 (1972-04-01), Weinstock et al.
patent: 3729469 (1973-04-01), Wasson
patent: 4195085 (1980-03-01), Stone
patent: 4521414 (1985-06-01), Chiou et al.
patent: 4539317 (1985-09-01), Baldwin et al.
patent: 4539318 (1985-09-01), Baldwin et al.
patent: 4623652 (1986-11-01), Erhardt et al.
patent: 4911920 (1990-03-01), Jani et al.
Wasson et al., J. Med. Chem., 15(6):651-655 (1972).
Heel et al., Drugs, 17:38-55 (1979).
L. Bonomi et al., "Comparison of the Effects of Nine Beta-Adrenergic Blocking Agents on Intraocular Pressure in Rabbits," Graefes Archiv Ophthalmologie, vol. 210, 1:1-8 (1979).
Ph. Dorosz' Guide Pratique des Medicaments, 818-819 (1987).
Tocco et al., "Timolol Metabolism in Man and Laboratory Animals," Drug Metabolism and Disposition, vol. 8, 4:236-240.
Adamski Robert J.
DeSantis, Jr. Louis
Alcon Laboratories Inc.
Azpuru Carlos
Cheng Julie J. L.
Page Thurman K.
LandOfFree
Topical ophthalmic compositions comprising 4-(3-substituted amin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical ophthalmic compositions comprising 4-(3-substituted amin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical ophthalmic compositions comprising 4-(3-substituted amin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247596